In Alzheimer’s and Parkinson’s disease, ATF2 expression is downregulated in the hippocampus and caudate nucleus (Pearson et al. 2005), indicating that ATF2 is essential for neuronal viability and normal neurological functions. This evidence concerns the gene ATF2 and Parkinson disease.